We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Gluten Vaccine: Phase 2 Trial Underway

News   Nov 01, 2018 | Original story from ImmunsanT

 
Gluten Vaccine Trial: Enrolment Opens for Phase 2

This study will test if Nexvax2 can specifically target the immune response to gluten in people with celiac disease and modify associated symptoms. Photo credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Risk of Pre-Eclampsia Related to Blood Pressure and BMI

News

New research has revealed that the genetic risk of pre-eclampsia is related to blood pressure and body mass index.

READ MORE

“Molecular Clock” Blood Test Could Be Used To Track Metastatic Breast Cancer

News

A blood test to watch breast cancer’s "molecular clock" could help track the growth of multiple tumors around the body.

READ MORE

Model Designed To Predict Cellular Drug Targets Against COVID-19

News

A computational model of a human lung cell has been used to understand how SARS-CoV-2 draws on human host cell metabolism to reproduce.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE